Kevin Reilly
Managing Director @ Ally Bridge Group
New York, United States
Kevin Reilly is a private equity investor at Ally Bridge Group in New York focused on Health Care and Medical Device. Kevin Reilly is the Managing Director at Ally Bridge Group.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 89%
Last updated:
For AI agents: llms.txt
Industries Kevin Reilly invests in
Stages Kevin Reilly invests in
Countries Kevin Reilly invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (67%)
- Medical Device 4 (44%)
- Medical 3 (33%)
- Biotechnology 2 (22%)
- Dental 1 (11%)
Stage
- Private Equity 2 (22%)
- Series D 1 (11%)
- Series F 1 (11%)
- Series G 1 (11%)
- Funding Round 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today. Founded in 2016, Calyxo is led by executives and investors with a strong track record of commercializing paradigm-shifting solutions in thefield of urology. Our team features some of the most talented, high-achieving and brightest minds in the medical device industry who are compelled by a desire to make a difference in kidney stone care. We are proud of our collaborative, diverse, fun and dynamic culture. | $40M / Series F / Apr 14, 2026 | ||
| Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | $32.5M / Private Equity / Jan 13, 2025 | ||
| Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | Jan 13, 2025 | ||
| Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients. | $196M / Private Equity / Jul 24, 2024 | ||
| LightForce Orthodontics, founded in 2015, makes the world’s first and only fully customized 3D-printed bracket system that is based on the anatomy and tooth morphology of each patient. The company’s mission is to apply modern technology and mass-customization to improve the orthodontic experience for both patients and doctors. LightForce’s platformunites the latest in digital treatment capabilities with cutting-edge, on-demand, 3D manufacturing to offer clinicians the first significant advancement in bracket-based treatment protocol in the past 50 years. A first-of-its-kind in the orthodontic space, Lightforce offers an unparalleled platform for orthodontists and LightForce technicians to collaborate on treatment plans for each individual patient. The company’s solution significantly reduces patient visits to the orthodontist and time spent wearing braces by providing 100 percent fully-customized solutions that improve both convenience and quality, ensuring patients receive the gold standard of care. | $80M / Series D / Aug 02, 2023 | ||
| Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $50M / Series G / Mar 27, 2023 | ||
| Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | $60M / Private Equity / Jun 16, 2022 | ||
| Treace Medical Concepts operates as a privately-funded, commercial-stage company focused on bringing breakthrough technologies to the high-growth $1.1 billion US market for foot and ankle surgical products. The company's mission is to assist foot and ankle physicians in improving patient outcomes and reducing healthcare costs while providing arewarding experience for ITS employees and an exceptional return for its shareholders. | $50M / Debt Financing / Aug 04, 2020 | ||
| See all 9 investments → | |||
Co-Investors
About Ally Bridge Group
Ally Bridge Group is a healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing. Ally Bridge Group focuses on both private and public equity investments, with a particular emphasis on pioneering life sciences companies and technologies. The firm is dedicated to bridging the gap betweengroundbreaking healthcare innovations and global markets. By leveraging its expertise and extensive network, Ally Bridge Group supports the growth and development of its portfolio companies. Its investment strategy is centered on transformative technologies and solutions that address major unmet medical needs.
Ally Bridge Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Steven Plachtyna
Vice President
|
|||
|
Arthur Kuan
Founding Member
|
|||
|
Dayu Teng
Venture Partner
|
|||
|
Frank Yu
Founder and CEO
|
|||
|
Kevin Reilly
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kevin Reilly invest in?
Kevin Reilly invests primarily in Health Care, Medical Device and Medical startups, most often at Private Equity and Series D stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kevin Reilly?
Public channels for Kevin Reilly include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kevin Reilly last invest?
The most recent investment recorded for Kevin Reilly closed in Apr 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
